LifevantagevsMerck & Company

LFVN and MRK stock compared: price, dividend, valuation and results, from SEC filings.

LFVN

Lifevantage Corporation

$4.77

Value $60M

-4.02%
LFVN's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

Lifevantage (LFVN) has a market value of $60M and Merck & Company (MRK) $357B. Over the last year, with dividends, LFVN moved -25.8% and MRK +60.0%. The P/E is 22.0 for LFVN and 145.6 for MRK. Dividend yield: LFVN 3.98%, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LFVN$60M

    MRK$357B

    MRK is 5,977 times LFVN

  • Revenue, 12 months

    LFVN$172M

    MRK$67.4B

    MRK is 391 times LFVN

  • Net income, 12 months

    LFVN$2.7M

    MRK$2.5B

    MRK is 902 times LFVN

  • Operating margin

    LFVN2.2%

    MRK–

  • ROIC

    LFVN8.3%

    MRK3.9%

    4.4 points apart

  • P/E

    LFVN22.0

    MRK145.6

    MRK is 6.6 times LFVN

  • Dividend yield

    LFVN4.0%

    MRK2.4%

    1.6 points apart

  • 5-year return

    LFVN-21.5%

    MRK+101.1%

    122.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LFVN-21.5%

MRK+101.1%

20040020222023202420252026
Returns by period
PeriodLFVNWith dividendsMRKWith dividends
1 year since November 14, 2025-25.8%Price -27.9%+60.0%Price +55.5%
3 years since November 16, 2023+3.9%+1.3% a yearPrice -2.5%+55.2%+15.8% a yearPrice +41.6%
5 years since November 15, 2021-21.5%-4.7% a yearPrice -33.4%+101.1%+15.0% a yearPrice +72.6%
10 years since November 16, 2016-29.1%-3.4% a yearPrice -39.8%+228.0%+12.6% a yearPrice +141.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LFVNLifevantageMRKMerck & Company

Valuation

LFVNMRK
Valuation
Price$4.77$144.46
Market value$60M$357B
Enterprise value (EV)$46M$401B
P/E22.0145.6
P/E, 5-year median18.114.8
P/B1.88.0
EV/EBIT12.584.3
Free cash flow yield14.6%4.1%

Results and growth

LFVNMRK
Results and growth
Revenue, 12 months$172M$67.4B
Net income, 12 months$2.7M$2.5B
Free cash flow, 12 months$8.7M$14.7B
Earnings per share, 12 months$0.21$0.98
Revenue growth, year on year-20.1%1.3%
Revenue growth a year, past-3.7%over 5 years+9.4%over 5 years
EPS growth a year, past-15.0%over 5 years+21.2%over 5 years

Margins and returns on capital

LFVNMRK
Margins and returns on capital
Gross margin76.5%71.8%
Operating margin2.2%–
Net margin1.6%3.6%
ROIC8.3%3.9%
ROE8.2%5.2%

Balance sheet

LFVNMRK
Balance sheet
Cash$14M$9.7B
Total debt$9.4M$53.8B
Net debt / EBITDA-2.15.7
Interest cover–2.4×

Dividends and buybacks

LFVNMRK
Dividends and buybacks
Dividend yield4.0%2.4%
Dividend per share, 12 months$0.19$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield3.4%1.4%
Shareholder yield7.4%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LFVN or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Lifevantage or Merck & Company?

By market value, Merck & Company ($357B) is about 5,977.1 times Lifevantage ($60M), at today's prices.

How did LFVN and MRK stock do over the last 10 years?

Since November 16, 2016, LFVN's price moved -39.8% and MRK's +141.7%. With dividends: LFVN -29.1% (-3.4% a year), MRK +228.0% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, LFVN or MRK?

The dividend yield at today's price is 3.98% for Lifevantage and 2.35% for Merck & Company. Over the last twelve months they paid $0.19 and $3.40 per share.

What is the P/E of LFVN and MRK?

At today's price, the P/E is 22.0 for LFVN and 145.6 for MRK. The median of the last five years was 18.1 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Lifevantage or Merck & Company?

Over the last twelve months, the net margin was 1.6% for Lifevantage and 3.6% for Merck & Company, and the operating margin 2.2% and –. Revenue was $172M and $67.4B.

Which is the better investment, Lifevantage or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.